GeneBioTech Co Dividend
The Dividend of GeneBioTech Co (086060.KQ) as of Oct 9, 2026 is 30.00 KRW. In the previous year, Dividend was 30.00 KRW — a change of 0.00% (lower).
Get this data via API
Financial Data API
Dividend
30.00KRW
YoY
0.00%
Dividend yield
0.59 %
Last updated:
How much dividend does GeneBioTech Co 2026 pay?
According to the latest status from October 2026, GeneBioTech Co paid a total of 30.00 KRW per share in dividends within the last 12 months. With the current GeneBioTech Co price of 5,070.00 KRW, this corresponds to a dividend yield of - %. A dividend is paid times per year.
At today's price the dividend yield works out to roughly 0.59%. The payout ratio is around 17% of earnings.
Historical GeneBioTech Co Dividends
| Paydate | Dividend |
|---|---|
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 30.00KRW | |
| 50.00KRW | |
| 50.00KRW | |
| 50.00KRW | |
| 25.00KRW | |
| 50.00KRW | |
| 50.00KRW |
The GeneBioTech Co Dividend history
3 Years
10 Years
25 Years
Max
| YEAR | Dividend | YoY |
|---|---|---|
| 0.00KRW | — | |
| 0.00KRW | — | |
| 0.00KRW | — | |
| 0.00KRW | -100.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | 0.00% | |
| 30.00KRW | -40.00% | |
| 50.00KRW | 0.00% | |
| 50.00KRW | 0.00% | |
| 50.00KRW | +100.00% | |
| 25.00KRW | -50.00% | |
| 50.00KRW | 0.00% | |
| 50.00KRW | — |
Is the GeneBioTech Co Dividend Safe?
GeneBioTech Co has been increasing the dividend for 0 years.
Analysts expect a Dividend Cut of -100.00% for the current fiscal year.
GeneBioTech Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Dividend Details
Understanding GeneBioTech Co's Dividend Distributions
GeneBioTech Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining GeneBioTech Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
GeneBioTech Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in GeneBioTech Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
GeneBioTech Co Stock analysis
Frequently Asked Questions about GeneBioTech Co stock
The current dividend yield of GeneBioTech Co is 0.59 %.
GeneBioTech Co pays a dividend, distributed in the months of December.
GeneBioTech Co paid dividends every year for the past 0 years.
GeneBioTech Co is assigned to the 'Health' sector.
To receive the latest dividend of GeneBioTech Co from 4/5/2021 amounting to 30 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2020.
The last dividend was paid out on 4/5/2021.
In the year 2021, GeneBioTech Co distributed 30 KRW as dividends.
The dividends of GeneBioTech Co are distributed in KRW.
All Key Metrics — GeneBioTech Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth